Kolexia
Tachon Gaelle Pharmacien
Tachon Gaelle
Pharmacien
Centre Léon-Bérard
Lyon, France
51 Activités
88 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Glioblastome Adénocarcinome Gliome Métastase tumorale Instabilité des microsatellites Tumeurs du cerveau Tumeurs du poumon Tumeurs du pancréas

Collaborateurs

Voir plus
Karayan-Tapon Lucie
Karayan-Tapon Lucie
Hôpital La Miletrie, Poitiers, France
Tougeron David
Tougeron David
Hôpital La Miletrie, Poitiers, France
Evrard Camille
Evrard Camille
Hôpital La Miletrie, Poitiers, France
Wager Michel
Wager Michel
Hôpital La Miletrie, Poitiers, France

Industries

Voir plus
AstraZeneca
3 collaboration(s)
Dernière en 2023
Janssen
2 collaboration(s)
Dernière en 2022
Ipsen
1 collaboration(s)
Dernière en 2023
MSD
1 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Circulating tumor DNA in unresectable pancreatic cancer is a strong predictor of first-line treatment efficacy: The KRASCIPANC prospective study.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   10 juin 2023
Heterogeneity of Mismatch Repair Status and Microsatellite Instability between Primary Tumour and Metastasis and Its Implications for Immunotherapy in Colorectal Cancers.
International journal of molecular sciences   17 avril 2022
HSP110 as a Diagnostic but Not a Prognostic Biomarker in Colorectal Cancer With Microsatellite Instability.
Frontiers in genetics   03 janvier 2022
MEOX2 Transcription Factor Is Involved in Survival and Adhesion of Glioma Stem-like Cells.
Cancers   25 novembre 2021
Standardisation of pathogenicity classification for somatic alterations in solid tumours and haematologic malignancies.
European journal of cancer (Oxford, England : 1990)   23 octobre 2021
1472P Circulating tumor DNA in unresectable pancreatic cancer is a strong predictor of response to first-line therapy: The KRASCIPANC study
Abstract Book of the ESMO Congress 2021, 16 – 21 September 2021   01 septembre 2021
462P Heterogeneity of mismatch repair status between primary tumors and matched metastases in metastatic colorectal cancer
Abstract Book of the ESMO Congress 2021, 16 – 21 September 2021   01 septembre 2021
Discordance between immunochemistry of mismatch repair proteins and molecular testing of microsatellite instability in colorectal cancer.
ESMO open   28 avril 2021
Impact de la méthode de segmentation dans la caractérisation des adénocarcinomes pulmonaires en TEP-TDM au 18FDG
Médecine Nucléaire   01 février 2021
CIrculating Tumor DNA for Monitoring Response to First Line Chemotherapy in Unresectable PANcreatic Cancer: KRAS (Kirsten Rat Sarcoma) Mutant CIrculating Tumor DNA for Monitoring Response to First Line Chemotherapy in Locally Advanced and Metastatic PANcreatic Cancer
Essai Clinique (CHU Poitiers)   17 septembre 2020